Persistent genital infection with high-risk (HR) human papillomavirus (HPV) is a prerequisite for cervical cancer development. The aim of this study was to identify factors associated with type-specific persistence of HR HPV infections. From a population-based cohort of 40,399 women participating in cervical cancer screening established during 2002-2005, we selected all HR HPV-positive women (N 5 7,778). During follow-up (2005During follow-up ( -2008, we collected cervical samples from these women and tested them for HPV DNA to determine type-specific HR HPV persistence in the interval 1-4.5 years after enrolment. Data on hospitalisations, prescriptions and socioeconomic factors were obtained from nationwide registers. Women with abnormal cytology at baseline or who had undergone conisation during follow-up were excluded. Factors associated with persistence were identified by logistic regression analysis. The overall rate of HR HPV persistence was 31.4%. The risk for persistence was significantly increased among women with a previous episode of genital warts (OR, 1.35; 95% CI, 1.04-1.74), current use of oral contraceptives (OR, 1.35; 95% CI, 1.13-1.63) or use of systemic glucocorticoids (OR, 2.04; 95% CI, 1.16-3.56). The number of pregnancies or births or use of a hormonal intrauterine device, hormonal therapy or nonsteroidal antiinflammatory drugs was not associated with risk for HR HPV persistence. A history of genital warts and current use of oral contraceptives or systemic glucocorticoids increased the risk, potentially indicating a decreased immune response to HPV infection. These findings suggest that host immune response characteristics are important in HR HPV persistence and consequently in cervical cancer development.Human papillomavirus (HPV) is one of the most frequent sexually transmitted infections. Most cases of genital HPV infection are transient and regress spontaneously, but some become persistent and can eventually progress to cervical cancer. As persistence of high-risk (HR) genital HPV infection is considered a prerequisite for cervical cancer development, 1 it is important to increase knowledge about the factors associated with persistence of HR HPV infections. In investigating risk factors for cervical cancer development, the steps in cervical carcinogenesis must be distinguished, i.e., between HPV acquisition, HPV persistence and progression to high-grade intraepithelial lesions or cervical cancer and persistence must be defined, as the definitions of HPV persistence vary, depending on the interval between examinations and the frequency of testing.It is well established that smoking, high parity and use of oral contraceptives increase the risk for cervical cancer.2 Furthermore, these factors as well as aspects of sexual behaviour including other sexually transmitted infections and impaired host immune response have been suggested to act by increasing the risk for HPV persistence. 3 An impaired immune response, as in HIV-infected individuals, has been found consistently to be a strong risk ...